enVVeno - NVNO Net Assets per Single Share

Graphic logo of enVVeno (NVNO)

Industry experts manage the enVVeno Medical (NVNO) team, ensuring trial transparency and strict compliance with FDA regulations. Manufacturing processes and bioprosthesis logistics are delegated to external contractors. The change in BVPS demonstrates net asset dynamics, where the 30.45 mark reflects the latest data. High R&D expenditures and patent protection create significant barriers to entry for new players in the venous surgery segment.

enVVeno - NVNO Net Assets per Share (period 07/04/2022 - 10/28/2026)

Summary analytical data breakdowns for envveno.com (NVNO)

- price and consensus price forecast:
Price Chart enVVeno|NVNO - Broker Consensus Forecast
- market capitalization data:
Market Value enVVeno Medical Corp.|NVNO - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share enVVeno Medical|NVNO - Book Valuation of Business|Market Value to Book Value Ratio envveno.com|NVNO - Total Asset Value of Company
- debt and liquidity data:
Total Debt to Capital enVVeno Medical|NVNO - Long-Term Liabilities to Capital|Short-Term Debt to Capital enVVeno Medical Corp.|NVNO - Company Total Debt|Debts to Book Capitalization enVVeno Medical Corp.|NVNO - Long-Term Debt Volume|Company Short-Term Debts enVVeno Medical
Analysis of all company metrics:enVVeno NVNO
Finished products of envveno.com

Book value per share represents the ratio of a company's net equity to the number of its securities, determining the actual value of a single share upon the liquidation of all liabilities. For enVVeno Medical (NVNO), the book value per share reflects the resource base for the commercialization of implants in the growing vascular center market, confirming the fundamental stability of the business.

Competitors of enVVeno Medical (NVNO)

Boston Scientific Inc (BSX) - Net Assets per Single Share|EW: Equity per Share|Net Assets per Single Share RMD|PODD (insulet.com) - Net Asset Value per Share|ZBH: Net Assets per Single Share|Net Assets per Share COO|ALGN - Net Assets per Single Share|Share Book Value NuVasive (GMED)|TMDX: Book Value per Share|Net Asset Value per Share atecspine.com ATEC|AORT: Book Value per Share|ENOV - Accounting Value per Share|Integra - Book Value per Share|Establishment Labs Inc (ESTA) - Net Assets per Share|BBNX (Beta Bionics Inc) - Book Value per Share|Book Value per Share IRMD|Net Assets per Single Share Embecta (EMBC)|Net Assets per Single Share Tandem Diabetes Care Inc (TNDM)|Book Value per Share AXGN|SIBN - Net Assets per Share|Accounting Value per Share Orthofix Medical Inc.|BVS - Share Book Value|Book Value per Share KIDS|Treace Medical Concepts Inc (TMCI) - Net Asset Value per Share|Book Value per Share Strata Critical Medical Corp (SRTA)|Equity per Share Carlsmed Medical (CARL)|RxSight, Inc. (RXST) - Accounting Value per Share|Accounting Value of a Share CLPT (clearpointneuro.com)|Stereotaxis - Net Assets per Single Share|Accounting Value per Share Neuronetics Inc. STIM|SGHT (Sight Sciences, Inc) - Book Value per Share|OBIO - Net Asset Value per Share|Book Value per Share anikatherapeutics.com|inspiremd.com (NSPR) - Equity per Share|ZJYL: Book Value per Share|Net Assets per Share Vivani|Book Value per Share XTNT (Xtant Medical Holdings)|Accounting Value per Share NeuroOne Medical Technologies Corp. (NMTC)|Book Value per Share MODD (Modular Medical, Inc.)|myomo.com - Book Value per Share|COCH - Net Assets per Single Share|Vivos Therapeutics Inc. (VVOS) - Net Assets per Single Share|Accounting Value per Share sintx.com SINT|Tenon Medical Inc (TNON) - Accounting Value of a Share|Book Value per Share LFWD (ReWalk Robotics Ltd.)|Net Asset Value per Share AMIX|IVF: Net Assets per Single Share|Book Value of One Share Bone Biologics Corp. BBLG|Accounting Value per Share AXNX (Axonics Modulation Technologies)|Book Value per Share Biolase Inc. BIOL|Book Value per Share DYNT (Dynatronics Corp.)|FNA: Net Assets per Share|Net Assets per Single Share invobioscience.com (INVO)